| 摘要 |
PROBLEM TO BE SOLVED: To provide an analog of GLP-1 useful for the treatment of diabetes, osteoporosis, neurodegenerative disease, hypertension, etc., and having higher activity or higher metabolic stability than the metabolically unstable native glucagon-like peptide-1 (GLP-1). SOLUTION: The pharmaceutical composition useful for the treatment of mammals contains an active amount of a peptide analog of a glucagon-like peptide-1 or its pharmacologically permissible salt and a pharmacologically permissible carrier or diluent. COPYRIGHT: (C)2004,JPO |
